BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19188507)

  • 1. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
    van Werkum JW; Heestermans AA; de Korte FI; Kelder JC; Suttorp MJ; Rensing BJ; Zwart B; Brueren BR; Koolen JJ; Dambrink JH; van't Hof AW; Verheugt FW; ten Berg JM
    Circulation; 2009 Feb; 119(6):828-34. PubMed ID: 19188507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
    de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
    J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
    Jensen LO; Maeng M; Kaltoft A; Thayssen P; Hansen HH; Bottcher M; Lassen JF; Krussel LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Soerensen HT; Thuesen L
    J Am Coll Cardiol; 2007 Jul; 50(5):463-70. PubMed ID: 17662400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
    Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
    J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
    Sheiban I; Garrone P; Sillano D; Biondi-Zoccai G; Sciuto F; Omedè P; Lombardi P; Meliga E; Anselmino M; Trevi GP; Moretti C
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1246-53. PubMed ID: 19001932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
    Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Lagerqvist B; Carlsson J; Fröbert O; Lindbäck J; Scherstén F; Stenestrand U; James SK;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):401-8. PubMed ID: 20031749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
    Wenaweser P; Daemen J; Zwahlen M; van Domburg R; Jüni P; Vaina S; Hellige G; Tsuchida K; Morger C; Boersma E; Kukreja N; Meier B; Serruys PW; Windecker S
    J Am Coll Cardiol; 2008 Sep; 52(14):1134-40. PubMed ID: 18804739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
    Zahn R; Hamm CW; Schneider S; Zeymer U; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA; Senges J;
    Am Heart J; 2006 Dec; 152(6):1146-52. PubMed ID: 17161068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
    Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
    Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
    Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
    van Werkum JW; Heestermans AA; Zomer AC; Kelder JC; Suttorp MJ; Rensing BJ; Koolen JJ; Brueren BR; Dambrink JH; Hautvast RW; Verheugt FW; ten Berg JM
    J Am Coll Cardiol; 2009 Apr; 53(16):1399-409. PubMed ID: 19371823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
    Palmerini T; Dangas G; Mehran R; Caixeta A; Généreux P; Fahy MP; Xu K; Cristea E; Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2011 Dec; 4(6):577-84. PubMed ID: 22028471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.
    Daemen J; Kukreja N; van Twisk PH; Onuma Y; de Jaegere PP; van Domburg R; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1105-11. PubMed ID: 18394442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
    Ahmed WH; Zambahari R; Al-Rashdan I; Al Naeemi A; Saeed FA; Mascioli S
    J Interv Cardiol; 2008 Dec; 21(6):512-8. PubMed ID: 18973513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.